Conatus Pharmaceuticals Inc. buy melinda
Start price
06.12.17
/
50%
€35.45
Target price
08.12.17
€36.98
Performance (%)
4.83%
End price
08.12.17
€37.16
Summary
This prediction ended on 08.12.17 with a price of €37.16. The BUY prediction by melinda finished with a performance of 4.83%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Conatus Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -1,76 % | 1,67 % | 2,10 % | 51,75 % |
| iShares Nasdaq 100 | 2,32 % | 12,78 % | 38,81 % | 96,06 % |
| iShares Nikkei 225® | 5,02 % | 13,30 % | 60,10 % | 71,80 % |
| iShares S&P 500 | 0,80 % | 6,20 % | 25,36 % | 68,52 % |
Comments by melinda for this prediction
In the thread Conatus Pharmaceuticals Inc. diskutieren
Biotechnologie und medizinische SecteurRecherche
A +
(Zielkurs erreicht)
Stopped prediction by melinda for Conatus Pharmaceuticals Inc.
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.46
02.04.19
02.04.19
€19.84
30.10.19
30.10.19
-79.93%
30.10.19
30.10.19
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.61
11.12.18
11.12.18
€27.06
09.01.19
09.01.19
29.63%
09.01.19
09.01.19
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.48
06.02.17
06.02.17
€49.61
30.03.17
30.03.17
5.62%
30.03.17
30.03.17


